These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2389694)

  • 21. Pharmacokinetic and pharmacodynamic interaction of nadolol with itraconazole, rifampicin and grapefruit juice in healthy volunteers.
    Misaka S; Miyazaki N; Yatabe MS; Ono T; Shikama Y; Fukushima T; Kimura J
    J Clin Pharmacol; 2013 Jul; 53(7):738-45. PubMed ID: 23677858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and metabolic response after abrupt uithdrawal of long-term propranolol.
    Myers JH; Horwitz LD
    Circulation; 1978 Aug; 58(2):196-201. PubMed ID: 566642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrupt withdrawal of pindolol or metoprolol after chronic therapy.
    Szécsi E; Kohlschütter S; Schiess W; Lang E
    Br J Clin Pharmacol; 1982; 13(Suppl 2):353S-357S. PubMed ID: 7104154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia.
    Leren IS; Saberniak J; Majid E; Haland TF; Edvardsen T; Haugaa KH
    Heart Rhythm; 2016 Feb; 13(2):433-40. PubMed ID: 26432584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac hyper- and hyporesponsiveness after pindolol withdrawal.
    Rangno RE; Langlois S; Stewart J
    Clin Pharmacol Ther; 1982 May; 31(5):564-71. PubMed ID: 7075106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withdrawal of beta-blocking drugs.
    Walden RJ; Hernandez J; Yu Y; Al-Khader A; Prichard BN
    Am Heart J; 1982 Aug; 104(2 Pt 2):515-20. PubMed ID: 6125098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectoris.
    Frishman WH; Klein N; Strom J; Cohen MN; Shamoon H; Willens H; Klein P; Roth S; Iorio L; LeJemtel T; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1191-5. PubMed ID: 6814227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related delay in recovery of beta-adrenergic sensitivity after abrupt propranolol withdrawal in rats.
    Teräväinen TL; Buñag RD
    Mech Ageing Dev; 1992 Mar; 63(1):91-103. PubMed ID: 1318480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
    Brenner BM; Duchin KL; Ichikawa I; Pfeffer J; Pfeffer M
    Am Heart J; 1984 Oct; 108(4 Pt 2):1144-7. PubMed ID: 6148876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol withdrawal supersensitivity in rat cardiovascular tissue, in vitro.
    Tenner TE
    Eur J Pharmacol; 1983 Aug; 92(1-2):91-7. PubMed ID: 6313393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of four beta-blockers as assessed by 24-hour ECG recording.
    Escoubet B; Leclercq JF; Maison-Blanche P; Poirier JM; Gourmel B; Delhotal-Landes B; Coumel P
    Clin Pharmacol Ther; 1986 Apr; 39(4):361-8. PubMed ID: 3956052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do beta blockers differ in their effects on hepatic microsomal enzymes and liver blood flow?
    Parker G; Ene MD; Daneshmend TK; Roberts CJ
    J Clin Pharmacol; 1984; 24(11-12):493-9. PubMed ID: 6150945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug- or hormone-induced adaptation: model of adrenergic hypersensitivity.
    Lima JJ; Krukemyer JJ; Boudoulas H
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):347-64. PubMed ID: 2572688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis.
    Wilkinson R; Burr WA
    Am Heart J; 1984 Oct; 108(4 Pt 2):1160-7. PubMed ID: 6148879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nadolol, propranolol, and thyroid hormones: evidence for a membrane-stabilizing action of propranolol.
    Reeves RA; From GL; Paul W; Leenen FH
    Clin Pharmacol Ther; 1985 Feb; 37(2):157-61. PubMed ID: 3967459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.
    Allely MC; Ungar A
    Br J Pharmacol; 1985 Oct; 86(2):393-8. PubMed ID: 2864972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 2001 Jun; 51(6):583-9. PubMed ID: 11422018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris.
    Lindenfeld J; Crawford MH; O'Rourke RA; Levine SP; Montiel MM; Horwitz LD
    Circulation; 1980 Oct; 62(4):704-11. PubMed ID: 7408143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.